Related Experiment Video
Updated: May 20, 2025
05:30
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
299
Proteomics of Extracellular Vesicles: Recent Updates, Challenges and Limitations
Mohini Singh1, Prashant Kumar Tiwari1, Vivek Kashyap2,3
1Department of Life Sciences, Sharda School of Basic Sciences and Research, Sharda University, Greater Noida UP-201310, India.
Proteomes
|March 26, 2025
Summary
Extracellular vesicles (EVs) are vital for cancer diagnosis and therapy, but current isolation methods yield impure samples. Improving EV isolation and proteomic analysis is key for biomarker discovery and therapeutic applications.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Extracellular vesicles (EVs), including exosomes and microvesicles, are secreted by cells and contain potential cancer biomarkers.
- Proteomic analysis of EVs is crucial for developing diagnostic and therapeutic strategies in oncology.
- Current EV isolation techniques (ultracentrifugation, chromatography, filtration) suffer from low purity and yield, hindering biomarker identification.
Purpose of the Study:
- To review the challenges associated with extracellular vesicle (EV) isolation and proteomic analysis.
- To highlight the limitations in current methods affecting biomarker discovery for cancer diagnosis and therapy.
- To provide an overview of the hurdles in EV characterization for future applications.
Main Methods:
- Literature review of extracellular vesicle (EV) isolation techniques.
- Analysis of proteomic analysis limitations in EV research.
- Discussion of challenges in EV yield and purity.
Main Results:
- Existing EV isolation methods often result in contamination, compromising downstream proteomic analysis.
- Low purity and yield of EVs impede the accurate identification of cancer-specific protein targets.
- Current proteomic tools face limitations in analyzing the complex EV landscape.
Conclusions:
- Refining EV isolation and characterization methods is essential for reliable biomarker discovery.
- Advancements in proteomics are needed to overcome current limitations in EV analysis.
- Improved EV research holds promise for enhanced cancer diagnostics, therapeutics, and drug delivery systems.
Related Concept Videos
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
01:33Proteomics
7.1K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.1K